Clinical impact of BRCA2 mRNA expression in high-grade serous ovarian cancer: validation using the TCGA cohort

Acta Oncol. 2021 Feb;60(2):187-190. doi: 10.1080/0284186X.2020.1841288. Epub 2020 Nov 4.
No abstract available

Publication types

  • Letter

MeSH terms

  • BRCA2 Protein* / genetics
  • Cohort Studies
  • Female
  • Humans
  • Ovarian Neoplasms* / genetics
  • RNA, Messenger / genetics

Substances

  • BRCA2 Protein
  • BRCA2 protein, human
  • RNA, Messenger